Charles Schwab’s Biomea Fusion BMEA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-116,549
Closed -$210K 3470
2025
Q2
$210K Sell
116,549
-64,831
-36% -$125K ﹤0.01% 3367
2025
Q1
$386K Sell
181,380
-18,990
-9% -$64.7K ﹤0.01% 3147
2024
Q4
$777K Sell
200,370
-8,021
-4% -$63.9K ﹤0.01% 2996
2024
Q3
$2.1M Buy
208,391
+7,551
+4% +$49.1K ﹤0.01% 2697
2024
Q2
$904K Buy
200,840
+21,905
+12% +$223K ﹤0.01% 2977
2024
Q1
$2.68M Buy
178,935
+2,138
+1% +$35.2K ﹤0.01% 2513
2023
Q4
$2.57M Buy
176,797
+2,369
+1% +$28.8K ﹤0.01% 2537
2023
Q3
$2.4M Buy
174,428
+119,001
+215% +$2.15M ﹤0.01% 2546
2023
Q2
$1.22M Buy
55,427
+47,747
+622% +$1.49M ﹤0.01% 2700
2023
Q1
$238K Buy
+7,680
New +$95.4K ﹤0.01% 3129
2022
Q2
Sell
-53,280
Closed -$238K 3551
2022
Q1
$238K Buy
53,280
+2,671
+5% +$17.3K ﹤0.01% 3277
2021
Q4
$378K Buy
50,609
+28,669
+131% +$303K ﹤0.01% 3235
2021
Q3
$263K Hold
21,940
﹤0.01% 3289
2021
Q2
$343K Buy
+21,940
New +$387K ﹤0.01% 3222

Other funds holding BMEA

Charles Schwab's BMEA Position: Q3 2025 in Review

Charles Schwab sold out of Biomea Fusion (BMEA) in Q3 2025, closing a stake of 116,549 shares — an estimated $210K sold.

Charles Schwab first reported a position in BMEA in Q2 2021 and held it in 14 quarters. The position peaked at $2.68M in Q1 2024. 73 funds tracked by Wall St. Rank hold BMEA as of Q3 2025.

  • Charles Schwab reported no remaining Biomea Fusion position as of Q3 2025 after selling out during the quarter.
  • Charles Schwab sold 116,549 Biomea Fusion shares in Q3 2025, an estimated $210K.
  • Charles Schwab first reported a position in Biomea Fusion in Q2 2021 and held it in 14 quarters.
  • Charles Schwab's Biomea Fusion position peaked at $2.68M in Q1 2024.
  • 73 funds tracked by Wall St. Rank held Biomea Fusion as of Q3 2025.

Based on Charles Schwab's 13F filing for Q3 2025, filed 10 Nov 2025.